Palisades Investment Partners, LLC Spring Works Therapeutics, Inc. Transaction History
Palisades Investment Partners, LLC
- $237 Billion
- Q4 2024
A detailed history of Palisades Investment Partners, LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Palisades Investment Partners, LLC holds 134,445 shares of SWTX stock, worth $8.06 Million. This represents 2.05% of its overall portfolio holdings.
Number of Shares
134,445
Previous 122,291
9.94%
Holding current value
$8.06 Million
Previous $3.92 Billion
23.97%
% of portfolio
2.05%
Previous 1.71%
Shares
2 transactions
Others Institutions Holding SWTX
# of Institutions
236Shares Held
67.2MCall Options Held
260KPut Options Held
316K-
Vanguard Group Inc Valley Forge, PA7.16MShares$429 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$337 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$207 Million5.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.27MShares$196 Million0.01% of portfolio
-
State Street Corp Boston, MA3MShares$180 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $3.74B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...